Details of the Drug Formulations

General Information of Drug (ID: DMJSBT6)

• Drug Name: SILODOSIN Drug Info
• Synonyms: Silodosin; 160970-54-7; Rapaflo; Urief; Silodyx; Urorec; KMD-3213; Silodosin-d6; UNII-CUZ39LUY82; KMD 3213; KAD 3213; CUZ39LUY82; CHEMBL24778; KAD-3213; (R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide; 1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide; 160970-64-9; Q-102517; Rapflo

Indication

Disease Entry	ICD 11	Status	REF
Benign prostatic hyperplasia	GA90	Approved	[1]

• Cross-matching ID:
  PubChem CID: 5312125
  ChEBI ID: CHEBI:135929
  CAS Number: 160970-54-7
  TTD ID: D0U0VU
  VARIDT ID: DR00285
  INTEDE ID: DR1482
  ACDINA ID: D01426

Full List of Drug Formulations Containing This Drug

Silodosin 8mg capsule

Company	Formulation ID	FDA Description
Allergan	F23893	D-Mannitol; Magnesium Stearate; Pregelatinized Starch; Sodium Lauryl Sulfate; Gelatin; Titanium Dioxide; Fd&C Blue No. 1 Aluminum Lake; Yellow Iron Oxide

Silodosin 4mg capsule

Company	Formulation ID	FDA Description
Allergan	F23894	D-Mannitol; Magnesium Stearate; Pregelatinized Starch; Sodium Lauryl Sulfate; Gelatin; Titanium Dioxide; Yellow Iron Oxide

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 493).